Based on those animal model studies, it is likely that subclinical, latent infection with Mp in the lower respiratory tracts may up-regulate TLR-2 expression on AMs and bronchial epithelial cells, which augments Mp reactivity. This evidence concerns the gene PPP1CB and disease arising from reactivation of latent virus.